The Butchart system of staging Mesothelioma cancer is commonly used for staging Pleural Mesothelioma, which manifest itself in the thin lining that surrounds the lungs. This system organizes Mesothelioma cases based on the size of the main tumor. It is one of the oldest forms of staging Mesothelioma cancer patient’s illness levels and treatments.
Eric G. Butchart M.D. developed the Butchart staging system. This staging system has been around since the early 70’s, and it is now used by a large number of Mesothelioma specialists because of its simplicity and relevance to prognosis and therapeutic options.
Treatments are also communicated by using roman numerals for example, Stage I, Stage II, Stage III and Stage IV.
Stage one with the Butchart system means that the cancer is present within the pleura on either side. This can also include the lung, pericardium, or the diaphragm.
Stage two means that the cancer is in the chest wall or involves the esophagus, heart, or pleura on both sides. The lymph nodes in the chest could also be cancerous.
Stage three means the cancer has now gone through the diaphragm into the peritoneum. The lymph nodes beyond those in the chest area can also be involved.
Stage four means that cancerous cells have spread to other organs of the body through the bloodstream, this is metastases Mesothelioma.
Treatment options for all four stages include:
With palliative treatment taking priority in the latter stages of Mesothelioma Cancer.
There is no cure for Mesothelioma now in use but, many patients wish to under go Mesothelioma treatments to combat the cancer and to ease suffering. Some victims volunteer for clinical trials done to test new experimental treatments and medications before they become available and recommended for public use. These clinical trials are very important in the search for a Mesothelioma cure. Information learned from trial studies results can really help doctors and scientists to get closer to the discovery of a cure for Mesothelioma cancer.